With more rapid advances in potential treatments for brain tumours, the number of clinical
trials for brain tumour patients is rising. In the context of the challenges of recruitment and …

American Society of Clinical Oncology (ASCO), the largest clinical oncology meeting in the
USA, meets annually and consistently provides an exciting forum to present new cancer …

Glioblastoma is the most common primary brain malignancy and is associated with poor
prognosis despite aggressive local and systemic therapy, which is related to a paucity of …

Brain Tumors | Neuro-oncology | JAMA | JAMA Network [Skip to Navigation] Our website
uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," …

Little in my 33 years as a pediatric oncology nurse practitioner prepared me to participate in
the Heads-Up Conference held at Camp Mak-A-Dream in Gold Creek, MT, last summer …

BACKGROUND: Patient advocates are increasingly involved in cooperative group trials,
single‐institution cancer programs, and peer‐review of research applications. The purpose …

Glioblastoma multiforme (GBM) is the most common malignant brain tumor in adults.
Although multiple clinical and tumor-related variables affect survival outcomes, the effect of …

To the Editor We noted with interest the article by Sharma et al. on the longitudinal
perception of prognosis in newly-diagnosed high grade glioma patients and caregivers …

To determine the variability in processes of care in the last 6 months of life experienced by
patients dying of primary intracranial tumors and potential predictors of place of death, a …

In this Training Matters article, the authors highlight the need for neurologists to develop
advocacy skills that they can use to promote high-priority issues facing the practice of …